APA

Savitz J., Hodgkinson C. A., Martin-Soelch C., Shen P., Szczepanik J., Nugent A. C., Herscovitch P., Grace A. A., Goldman D. & Drevets W. C. (20140401). DRD2/ANKK1 Taq1A polymorphism (rs1800497) has opposing effects on D2/3 receptor binding in healthy controls and patients with major depressive disorder. : The international journal of neuropsychopharmacology.

Chicago

Savitz Jonathan, Hodgkinson Colin A, Martin-Soelch Chantal, Shen Pei-Hong, Szczepanik Joanna, Nugent Allison C, Herscovitch Peter, Grace Anthony A, Goldman David and Drevets Wayne C. 20140401. DRD2/ANKK1 Taq1A polymorphism (rs1800497) has opposing effects on D2/3 receptor binding in healthy controls and patients with major depressive disorder. : The international journal of neuropsychopharmacology.

Harvard

Savitz J., Hodgkinson C. A., Martin-Soelch C., Shen P., Szczepanik J., Nugent A. C., Herscovitch P., Grace A. A., Goldman D. and Drevets W. C. (20140401). DRD2/ANKK1 Taq1A polymorphism (rs1800497) has opposing effects on D2/3 receptor binding in healthy controls and patients with major depressive disorder. : The international journal of neuropsychopharmacology.

MLA

Savitz Jonathan, Hodgkinson Colin A, Martin-Soelch Chantal, Shen Pei-Hong, Szczepanik Joanna, Nugent Allison C, Herscovitch Peter, Grace Anthony A, Goldman David and Drevets Wayne C. DRD2/ANKK1 Taq1A polymorphism (rs1800497) has opposing effects on D2/3 receptor binding in healthy controls and patients with major depressive disorder. : The international journal of neuropsychopharmacology. 20140401.